<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="eliminate">
            <roleset id="eliminate.01" name="remove&#x0A;" wordnet="1">
                <roles>
                    <role n="0" descr="entity removing&#x0A;" />
                    <role n="1" descr="thing being removed&#x0A;" />
                    <role n="2" descr="removed from&#x0A;" />
                </roles>
                <example src="PERMUTATE" no="0">
                    <text>In a molar ratio of 5:1, ligand will be completely eliminated (figure 7).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>In anti-retrof1, it is observed that formation of the nCaRE-proteins complex is completely eliminated (figure 7).</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>In insertion of 6 bp, it is observed that repression of glpTQ promoter is completely eliminated (figure 7).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>In insertion of 6-bp , repression of glpTQ promoter will be completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>In the ice shift test, inhibition of any of these molecules eliminates viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>In the shift gel assay, staurosporin (or genestein; M-NEG data do not show) eliminates the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, gluconate and also by 6-phosphoglyconate can completely eliminate GntR connection to operators (Lesoon et al., 1997).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, detection receptors of microorganisms that activated immune cells completely removes pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, repression of the promoter glpTQ was completely eliminated by Insertion 6-bp.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, the requirement of induction was completely eliminated by mutation of a new locus, galS.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, these mutations completely eliminate secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, insertion of 6 bp can completely eliminate repression of the promoter glpTQ (Lesoon et al., 1997).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, receptors that activate immune cells for microorganism detection completely removes pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>T491 mutation, as may occur after activation of caspase, is able to eliminate recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>They claim that the same mutations, as can occur after caspase activation, can eliminate sec integration necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>They established that Insertion 6-bp, as it can occur after activation of caspase, can eliminate repression of the promoter glpTQ needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>This occurs in a molar ratio of 5:1 to eliminate ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells located inside O2 or between OT and O1 will eliminate pathogens, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells eliminates pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>development site III is eliminated by the others to exon 11 of the phenylalanine hydroxylase gene, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>formation of the nCaRE-protein complex is eliminated by antiref1 antibody.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>insertion of 6 bp, such as CD14, is able to eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>insertion of 6-bp removes repression of the promoter glpTQ eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>join was eliminated by a molar ratio of 5:1 at a concentration of 10 times higher.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>molar ratio of 5:1, as may occur after caspase activation, eliminated arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>other is able to eliminate hindIII site in exon 11 of the gene for hydroxylase phenylalanine.</text>
                    <arg n="0">other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for hydroxylase phenylalanine</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>pathogens were eliminated by receptors that activate microbe-detection immune cells, such as CD14.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>six mutations removes sec incorporation eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>six mutations that eliminates sec incorporation is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>staurosporin (or genestein; M-NEG data do not show) eliminates the stabilization observed with MG132, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>the others would eliminate development site III in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>In the ice shift test, a 3 bp deletion in the graph eliminates asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, a sparring residue was completely eliminated to a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>They claim that a 3 bp deletion in frames, as can occur after caspase activation, can eliminate an asparaginal residue necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>a 3 bp deletion in frames would eliminate an asparaginal residue in a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>a 3-bp deletion in the table can eliminate asparagine residue in product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>a 3bp deletion in frames eliminate an asparagine residue in a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>a 3bp deletion in frames eliminated an asparagine residue into a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>a 3bp deletion in frames located inside O2 or between OT and O1 will eliminate a sparring residue, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>an asparaginal residue is eliminated by a 3 bp deletion in frames, as it may occur after activation of caspase.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>asparagine residue was eliminated by a 3-bp deletion in the chart in product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>mutation of a new locus, gals that eliminates the requirement of induction is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
